Brain health is built through systems, not shortcuts
Future Research Goals So far, most evidence comes from retrospective studies or case reports, not from large randomized clinical trials, says Tariq, who says that experts are still looking to understand: Whether GLP-1s directly reduce intestinal inflammation How GLP-1s interact with the immune system and the gut microbiome Whether they are as effective in people with active Crohns disease as with those in remission Current research findings show promise, but Tariq encourages her patients to view them as early signals instead of established treatments
The active ingredient, Sitagliptin, seems to provide a 0.8% reduction in A1C levels among patients with type 2 diabetes
When adding it to a lyophilised peptide vial, inject slowly down the inner glass wall rather than directly onto the powder, then swirl gently until dissolved and never shake or vortex
they act on growth hormone and incretin pathways respectively, and their use outside approved clinical trials is unsupported by robust clinical evidence